PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
1.030
+0.010 (0.98%)
Nov 20, 2024, 4:00 PM EST - Market closed
PAVmed Revenue
PAVmed had revenue of $996.00K in the quarter ending September 30, 2024, with 25.92% growth. This brings the company's revenue in the last twelve months to $4.03M, up 166.27% year-over-year. In the year 2023, PAVmed had annual revenue of $2.45M with 550.40% growth.
Revenue (ttm)
$4.03M
Revenue Growth
+166.27%
P/S Ratio
2.29
Revenue / Employee
$37,701
Employees
107
Market Cap
10.72M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Dominari Holdings | 12.59M |
MSP Recovery | 10.73M |
T2 Biosystems | 7.68M |
QT Imaging Holdings | 4.04M |
Alterity Therapeutics | 2.68M |
Lyra Therapeutics | 1.47M |
PAVM News
- 1 day ago - Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test - PRNewsWire
- 3 days ago - Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - PRNewsWire
- 6 days ago - PAVmed Inc. (PAVM) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - PAVmed Provides Business Update and Third Quarter 2024 Financial Results - PRNewsWire
- 8 days ago - Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial Results - PRNewsWire
- 14 days ago - Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication - PRNewsWire
- 16 days ago - Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers - PRNewsWire
- 21 days ago - PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024 - PRNewsWire